Seeing Is Believing
Currently out of the existing stock ratings of Madhu Kumar, 140 are a BUY (65.73%), 56 are a HOLD (26.29%), 17 are a SELL (7.98%).
Analyst Madhu Kumar, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 56.82% that have a potential upside of 44.37% achieved within 160 days.
Madhu Kumar’s has documented 446 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on DVAX, Dynavax Technologies at 01-Feb-2024.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 12/29/2020. The price target of $69 was fulfilled within 10 days with a profit of $26.64 (62.89%) receiving and performance score of 62.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5
$1.31 (35.50%)
5
1 months 19 days ago
0/15 (0%)
$1.8 (56.25%)
Buy
4
$0.31 (8.40%)
4
1 months 21 days ago
1/10 (10%)
$0.37 (10.19%)
139
Buy
4
$0.31 (8.40%)
4
3 months 22 days ago
0/5 (0%)
$1 (33.33%)
Buy
5
$2.08 (71.23%)
2 years 5 months 25 days ago
0/1 (0%)
$2.11 (73.01%)
Buy
7
3 years 28 days ago
0/4 (0%)
$3.7 (112.12%)
Which stock is Madhu Kumar is most bullish on?
Which stock is Madhu Kumar is most reserved on?
What Year was the first public recommendation made by Madhu Kumar?